Outcomes Network Graph
Outcomes Flow Chart
Treatment Effectiveness
User reported effectiveness ratings Imipramine (Tofranil) for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Neuropathy | 0% | 0% | 0% | 100% | 0% | 1 |
Side Effects
User-reported side effects of Imipramine (Tofranil)
| Side Effect | Percent of Reports Imipramine (Tofranil) |
|---|---|
| Constipation | 35% |
| Dry Mouth | 65% |
| Blurred Vision | 20% |
| Changes in Appetite or Weight | 27% |
| Changes in Sex Drive or Ability | 18% |
| Difficulty Urinating | 12% |
| Drowsiness | 45% |
| Excessive Sweating | 34% |
| Excitement or Anxiety | 26% |
| Frequent Urination | 10% |
| Nightmares | 12% |
| Skin More Sensitive to Sunlight Than Usual | 20% |
| Weakness or Tiredness | 44% |
| Nausea | 19% |
Outcomes
Below is the degree of change seen after Imipramine (Tofranil) is higher than average.
|
|
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Daily Distribution
Average by Year
Average by Month
Average by Day of Week
Outcomes Label
Imipramine (Tofranil) Info
| Property | Value |
|---|---|
| Variable Name | Imipramine (Tofranil) |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-10-09 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Kurtosis | 2.4823887170104 |
| Mean | 63.158 count |
| Median | 0 count |
| Minimum Allowed Value | 0 count |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 25 |
| Number of Measurements | 17 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 17 |
| Public | true |
| Onset Delay | 30 minutes |
| Standard Deviation | 82.760000233756 |
| Unit | Count |
| User Variables | 1 |
| Variable Category | Treatments |
| Variable ID | 93941 |
| Variance | 6849.2176386913 |